Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.

Pituitary - 1 Feb 2015

Cinar Nese, Dagdelen Selcuk, Yorgun Hikmet, Canpolat Ugur, Kabakçı Giray, Erbas Tomris

Abstract excerpt

PURPOSE: Exon 3-deleted GH receptor variant (d3-GHR) is associated with increased responsiveness to exogenous GH. The aim of this study was to determine the effect of d3-GHR polymorphism on the GH/IGF-1 relationship, clinical parameters, and comorbidity in acromegalic patients. METHODS: The study included 118 acromegalic patients (61 female and 57 male; mean age: 50.3 ± 12.2 years) and 108 healthy controls (94...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acromegaly
Share to GHR gene
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Receptors, Somatotropin

Source

Identifiers

PMID: 24706164
DOI: 10.1007/s11102-014-0564-y

Genes

GHR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.PMID 24706164Read ↗

d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.Semantic proximity Read ↗

Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.Semantic proximity Read ↗

Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene.Semantic proximity Read ↗

Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.Semantic proximity Read ↗

The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.Semantic proximity Read ↗

D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly.Semantic proximity Read ↗

The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly.Semantic proximity Read ↗

The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism - a Favorable Backdoor Mechanism for the GHR FunctionSemantic proximity Read ↗

Investigation of the vitamin D receptor polymorphisms in acromegaly patients.Semantic proximity Read ↗

The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly.Semantic proximity Read ↗

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3Semantic proximity Read ↗

Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.